VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

cellvie

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 86 out of 100

cellvie is employing Therapeutic Mitochondria Transplantation, a technique of augmentation and replacement to reinvigorate the cell energy metabolism when the mitochondria are failing.

Also known as cellvie Inc.

  • Biotech & therapeutics
Status
Operatingas of 2026-09-17Source (opens in a new tab)
Business model
B2B
Headquarters
Houston, Texas, United States
Legal name
cellvie Inc.
Claim, correct or request removal

Record updated 28 September 2026

About

Mitochondria are the powerhouses of the cell. cellvie is employing Therapeutic Mitochondria Transplantation, a technique of augmentation and replacement to reinvigorate the cell energy metabolism when the mitochondria are failing. The first application will be in ischemia-reperfusion injury, the world's number 1 killer.

Funding snapshot

Total raised
$5MSum of rounds, as of 2026-09-17Source (opens in a new tab)
Latest round
Undisclosed, $5M2025-09-09

Funding rounds

Round, 2025
$5M2025-09-09, Company stated
Grant
2024-10-24
Grant
2023-11-14
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy